Administration of tolvaptan (7.5mg/day) for a refractory ascites patients.

2 trials

Sponsors

The third department of internal medicine, Nara Medical University

Conditions

Liver cirrhosis with refractory ascites.

Unknown Phase

Multicenter study of Genome-Wide Association Study (GWAS) concerning of the efficacy of tolvaptan.

Active, not recruitingJPRN-UMIN000025905

The third department of internal medicine, Nara Medical UniversityLiver cirrhosis with refractory ascites.

Start: 2017-02-01Target: 300Updated: 2026-06-29

A Study on predictors of treatment response concerning of the efficacy of tolvaptan on refractory ascites.

Active, not recruitingJPRN-UMIN000026426

The third department of internal medicine, Nara Medical UniversityLiver cirrhosis with refractory ascites.

Start: 2017-01-01Target: 300Updated: 2026-06-29